Wang et al. found that CRISPR/Cas9-mediated knockout of SHP2, a tyrosine phosphatase involved in the regulation of immune cells signaling, in the human ovarian carcinoma cell line SHP09 inhibited its protein activity and enhanced tumor intrinsic IFN-γ signaling. Here, PTPN11 is linked to neoplasm.